Trials
2 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “CK0801 is an investigational allogeneic, cord blood-derived regulatory T-cell product administered by intravenous infusion. The planned dose is 1 x 10\^7 CK0801 Tregs/kg using actual body weight, capped at 100 kg.”In the company’s words, NCT07499102 on ClinicalTrials.gov
- Tested for
- Aplastic Anemia, Bone Marrow Disease
- Main trialPhase 2
- “This Phase 2, multicenter, open-label study is evaluating CK0801 for the treatment of aplastic anemia in adults with persistent transfusion dependence after at least one prior line of therapy or intolerance to standard-of-care treatment. CK0801 is an allogeneic cord blood-derived regulatory T-cell therapy administered intravenously. The study is designed to assess safety and clinical activity, including hematologic response, transfusion independence, duration of response, survival outcomes, and patient-reported outcomes. Exploratory assessments include immune reconstitution, biomarkers,…”In the company’s words, NCT07499102 on ClinicalTrials.gov
Other drugs for Aplastic Anemia
- AvatrombopagSwedish Orphan Biovitrum · Phase 2/3
- CM313Keymed Biosciences Co.Ltd · Phase 1/2
- DibotatugDren Bio · Phase 1/2
- RivogenlecleucelBellicum Pharmaceuticals · Phase 1/2
- APR-2020Apriligen, Inc. · Phase 1
- DSB2455Duke Street Bio Ltd · Phase 1
Coming up2
- 25 May 2027Phase 1 trial completes · ClinicalTrials.gov
- 3 Aug 2028Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Not yet recruiting | 3 Aug 2028 | CK0801 for Treatment of Aplastic Anemia | |
| Phase 1Active, not recruiting | 25 May 2027 | A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF) | |
| Phase 1Withdrawn | Feb 2025 | A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026